Stay updated on IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial
Sign up to get notified when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.

Latest updates to the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.4 was added, replacing the prior v3.5.3. This indicates a new site revision rather than a change to study data.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe site now shows a new release version label v3.5.3 in the release notes, replacing v3.5.2. This indicates a software update to ClinicalTrials.gov and does not modify the trial record or displayed content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new revision entry v3.5.0 to the Record History and removed the previous revision v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the Study Record Versions.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision label 'Revision: v3.4.2' was added and an operating-status notice about government funding was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.